Financial Analysis Of ZF Pharmaceutical Company Based On Harvard Analysis Framework

With the rapid development of China's economy,the improvement of people's living standard,the improvement of medical system policies in rural and urban areas,and the enhancement of citizens' health awareness,people's medical consumption level has been greatly improved,and the medical industry is full of new opportunities.At the same time,with the "price reduction order" and the release of the new version of GMP also brings great challenges to the pharmaceutical industry.As a representative of small and medium-sized private pharmaceutical companies,ZF pharmaceutical company has maintained the momentum of continuous development in recent years,but there are still problems and deficiencies in the operation and management.Therefore,based on the strategic perspective,this paper makes a comprehensive and comprehensive analysis of its financial status and business performance,summarizes the experience and reveals the deficiencies,which can not only provide reference for the operation and investors,but also provide certain reference significance for small and medium-sized private pharmaceutical companies.This paper USES the harvard analysis framework,takes ZF pharmaceutical company as the research object,selects the financial data of 2015-2018,and conducts a comprehensive analysis from the four dimensions of corporate strategy,accounting,finance and prospect.First,from a strategic perspective,the company analyzes the macroeconomic environment with PEST analysis,the competitive environment with porter's five forces model,analyzes its internal and external advantages with SWOT analysis and proposes the most suitable strategy for the company's development.Secondly,based on the company's selected strategy and the characteristics of the pharmaceutical industry,the key accounting elements are identified,and the accounting policies and accounting estimates are evaluated to improve the quality of accounting information and provide guarantee for subsequent financial analysis.Thirdly,in the financial analysis,the trend analysis ratio analysis method is used to compare ZF pharmaceutical company with its competitors in the same industry,so as to deeply analyze the debt paying ability,operating ability,profitability and development ability of ZF pharmaceutical company.Finally,the financial status and operating performance of the company are comprehensively evaluated through dupont analysis system.Finally,combined with the industry environment,this paper forecasts the future development prospect of ZF pharmaceutical company by using the qualitative and quantitative methods to reveal the risks.At the end of the paper,the problems in the operation of ZF pharmaceutical company are summarized through the above analysis and reasonable Suggestions are put forward.This paper believes that ZF pharmaceutical co,ltd.has both opportunities and challenges in the development of the industry.The company's current implementation strategy is clear and pragmatic,but the company has shortcomings in operation,such as adverse receivables collection policy,unreasonable asset structure,poor solvency and profitability,and a series of problems.In view of these problems,this paper provides reasonable Suggestions,provides reference value for managers and decision makers,and also provides reference significance for small and medium-sized private pharmaceutical companies that are expanding.